UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
--------------------------------------------------------------------------------


                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934



Date of report (Date of earliest event reported):   May 5, 2004
                                                  -------------

                         BIO-IMAGING TECHNOLOGIES, INC.
                         ------------------------------
               (Exact Name of Registrant as Specified in Charter)



Delaware                               1-11182                   11-2872047
--------------------------------------------------------------------------------
(State or Other Jurisdiction    (Commission File Number)       (IRS Employer
      of Incorporation)                                      Identification No.)




826 Newtown-Yardley Road, Newtown, Pennsylvania                        18940
--------------------------------------------------------------------------------
(Address of Principal Executive Offices)                            (Zip Code)


                                 (267) 757-3000
                                 --------------
                        (Registrant's telephone number,
                              including area code)



          ------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)





ITEM 7.     FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

     (a)      Not applicable.

     (b)      Not applicable.

     (c)      Exhibits.

              Exhibit No.               Description of Exhibit
              -----------               ----------------------

                 99.1                   Press release dated May 5, 2004.


ITEM 12.    DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     On May 5, 2004,  Bio-Imaging  Technologies,  Inc. (the "Company") announced
its financial  results for the first quarter ended March 31, 2004. The full text
of the press release issued in connection  with the  announcement is attached as
Exhibit 99.1 to this Current Report on Form 8-K.

     The  information in this Form 8-K and the Exhibit  attached hereto is being
furnished  under "Item 12.  Disclosure  of Results of  Operations  and Financial
Condition." The information  shall not be deemed "filed" for purposes of Section
18 of the Securities  Exchange Act of 1934, as amended (the "Exchange  Act"), or
otherwise  subject to the  liabilities  of that section,  nor shall it be deemed
incorporated  by reference in any filing under the  Securities  Act of 1933,  as
amended,  or the  Exchange  Act,  except  as  expressly  set  forth by  specific
reference in such a filing.






                                      - 2 -


                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.



                                 BIO-IMAGING TECHNOLOGIES, INC.



Dated: May 5, 2004               By: /s/ Mark L. Weinstein
                                    --------------------------------------------
                                    Name:  Mark L. Weinstein
                                    Title: President and Chief Executive Officer






                                  EXHIBIT INDEX


Exhibit No.                Description
-----------                -----------

 99.1                      Press release dated May 5, 2004.